Jazz Pharmaceuticals Webinar
Join us for a live webinar. Register today!
Rising to the Challenge of Veno-occlusive Disease (VOD): Advances in the Treatment of Post–hematopoietic Stem-Cell Transplantation (HSCT)
December 13, 2017
11:00am–12:00pm Central/12:00pm–1:00pm Eastern
Register today for this one-hour, live webinar to gain a better understanding of VOD and treatment with Defitelio® (defibrotide sodium), the first and only approved medication for VOD with renal or pulmonary dysfunction post-HSCT.
Katie S. Gatwood, PharmD, BCOP
Clinical Pharmacist, Stem Cell Transplant
Vanderbilt University Medical Center
- Understand VOD pathogenesis and risk factors
- Recognize VOD and the initial signs and symptoms of renal or pulmonary dysfunction
- Discuss proposed mechanism of action, clinical efficacy, and safety of Defitelio
- Review Defitelio dosing and administration
This free event is open to HOPA members and non-members.
Please note: There are no certified continuing education credits approved for this program.
Login instructions will be emailed to you upon registration.
Handouts for the webinar will be emailed to you 1-2 business days prior to the event.
Please click here for full Prescribing Information for Defitelio.
Questions about this webinar can be directed to: